Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1962 1
1963 3
1965 1
1967 1
1969 1
1971 1
1973 1
1979 1
1981 1
1982 2
1983 3
1984 1
1985 2
1986 4
1987 1
1989 2
1990 3
1991 4
1992 4
1993 3
1994 5
1995 5
1996 7
1997 5
1998 4
1999 2
2000 12
2001 3
2002 8
2004 3
2005 1
2009 1
2016 1
2018 2
2019 2
2020 4
2021 6
2022 6
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.
Lin CC, Garralda E, Schöffski P, Hong DS, Siu LL, Martin M, Maur M, Hui R, Soo RA, Chiu J, Zhang T, Ma B, Kyi C, Tan DS, Cassier PA, Sarantopoulos J, Weickhardt A, Carvajal RD, Spratlin J, Esaki T, Rolland F, Akerley W, Deschler-Baier B, Rispoli L, Samant TS, Chowdhury NR, Gusenleitner D, Kwak EL, Askoxylakis V, De Braud F. Lin CC, et al. Among authors: chowdhury nr. Oncoimmunology. 2023 Dec 20;13(1):2290787. doi: 10.1080/2162402X.2023.2290787. eCollection 2024. Oncoimmunology. 2023. PMID: 38170160 Free PMC article. Clinical Trial.
Glucuronidation and the UDP-glucuronosyltransferases in health and disease.
Wells PG, Mackenzie PI, Chowdhury JR, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Chowdhury NR, Ritter JK. Wells PG, et al. Among authors: chowdhury nr. Drug Metab Dispos. 2004 Mar;32(3):281-90. doi: 10.1124/dmd.32.3.281. Drug Metab Dispos. 2004. PMID: 14977861 Review.
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies.
Schöffski P, Tan DSW, Martín M, Ochoa-de-Olza M, Sarantopoulos J, Carvajal RD, Kyi C, Esaki T, Prawira A, Akerley W, De Braud F, Hui R, Zhang T, Soo RA, Maur M, Weickhardt A, Krauss J, Deschler-Baier B, Lau A, Samant TS, Longmire T, Chowdhury NR, Sabatos-Peyton CA, Patel N, Ramesh R, Hu T, Carion A, Gusenleitner D, Yerramilli-Rao P, Askoxylakis V, Kwak EL, Hong DS. Schöffski P, et al. Among authors: chowdhury nr. J Immunother Cancer. 2022 Feb;10(2):e003776. doi: 10.1136/jitc-2021-003776. J Immunother Cancer. 2022. PMID: 35217575 Free PMC article. Clinical Trial.
Conjugation and excretion of bilirubin.
Chowdhury JR, Chowdhury NR. Chowdhury JR, et al. Among authors: chowdhury nr. Semin Liver Dis. 1983 Feb;3(1):11-23. doi: 10.1055/s-2008-1040667. Semin Liver Dis. 1983. PMID: 6403990 Review. No abstract available.
Gene therapy as an alternative to liver transplantation.
Kren BT, Chowdhury NR, Chowdhury JR, Steer CJ. Kren BT, et al. Among authors: chowdhury nr. Liver Transpl. 2002 Dec;8(12):1089-108. doi: 10.1053/jlts.2002.36844. Liver Transpl. 2002. PMID: 12474147 Free article. Review.
Adenovirus-mediated gene therapy of liver diseases.
Ilan Y, Saito H, Thummala NR, Chowdhury NR. Ilan Y, et al. Among authors: chowdhury nr. Semin Liver Dis. 1999;19(1):49-59. doi: 10.1055/s-2007-1007097. Semin Liver Dis. 1999. PMID: 10349683 Review.
Recombinant adenoassociated virus in cancer gene therapy.
Guha C, Chowdhury NR, Chowdhury JR. Guha C, et al. Among authors: chowdhury nr. J Hepatol. 2000 Jun;32(6):1031-4. doi: 10.1016/s0168-8278(00)80109-9. J Hepatol. 2000. PMID: 10898325 Review. No abstract available.
121 results